Skip to main content
. 2015 Jan 5;33(7):716–722. doi: 10.1200/JCO.2014.57.2743

Table 2.

Distribution of Selected Characteristics Across Cohorts Before and After Propensity Score Adjustment

graphic file with name zlj00715-4958-t02.jpg

Characteristic RCT Cohort
Elderly Cohort
Screen-Detected Cohort
ADT
ADT Plus RT
P
ADT
ADT Plus RT
P
ADT
ADT Plus RT
P
No. % No. % Before After No. % No. % Before After No. % No. % Before After
All patients 4,642 35.9 8,282 64.1 8,694 60.6 5,646 39.4 2,017 47.2 2,260 52.8
Age, years .066 .959 < .001 .921 < .001 .725
    Mean 71.2 71.1 80.4 78.9 77.6 74.8
    SD 3.0 2.9 2.7 2.5 5.2 4.8
Race < .001 .896 < .001 .981 < .001 .954
    White 3,499 75.4 6,969 84.1 7,029 80.8 4,892 86.6 1,615 80.1 1,881 83.2
    Black 732 15.8 801 9.7 695 8.0 338 6.0 250 12.4 233 10.3
    All others 216 4.7 379 4.6 448 5.2 328 5.8 88 4.4 125 5.5
    Unknown 195 4.2 133 1.6 522 6.0 88 1.6 64 3.2 21 0.9
Ethnicity < .001 .906 < .001 .990 < .001 .995
    Non-Hispanic 4,050 87.2 7,599 91.8 7,648 88.0 5,276 93.4 1,839 91.2 2,118 93.7
    Hispanic 362 7.8 521 6.3 469 5.4 251 4.4 94 4.7 109 4.8
    Unknown 230 5.0 162 2.0 577 6.6 119 2.1 0 0.0 0 0.0
Marital status < .001 .960 < .001 .899 < .001 .900
    Married 2,594 55.9 5,832 70.4 4,709 54.2 3989 70.7 1,168 57.9 1,626 71.9
    Not married 1,077 23.2 1,668 20.1 1,787 20.6 1141 20.2 511 25.3 465 20.6
    Unknown 971 20.9 782 9.4 2,198 25.3 516 9.1 338 16.8 169 7.5
T stage < .001 .563 < .001 .957
    T1 0 0.0 0 0.0 0 0.0 0 0.0 2,017 100.0 2,260 100.0
    T2 4,329 93.3 7,435 89.8 8,283 95.3 5,168 91.5
    T3 313 6.7 847 10.2 411 4.7 478 8.5
WHO grade < .001 .984 < .001 .829
    1 137 3.0 148 1.8 215 2.5 84 1.5
    2 2,992 64.5 5,236 63.2 5,206 59.9 3,262 57.8
    3 1,513 32.6 2,898 35.0 3,273 37.6 2,300 40.7 2,017 100.0 2,260 100.0
Comorbidities (present)
    Congestive heart failure 551 11.9 750 9.1 < .001 .965 1,296 14.9 579 10.3 < .001 .929 344 17.1 246 10.9 < .001 .951
    Valvular 488 10.5 872 10.5 .999 .962 1,309 15.1 763 13.5 .011 .991 313 15.5 309 13.7 .096 .986
    Perivascular 668 14.4 1,005 12.1 < .001 .975 1,599 18.4 835 14.8 < .001 .912 375 18.6 346 15.3 .005 .955
    Stroke 371 8.0 422 5.1 < .001 .962 736 8.5 311 5.5 < .001 .863 179 8.9 137 6.1 < .001 .962
    Neurologic 302 6.5 324 3.9 < .001 .950 724 8.3 273 4.8 < .001 .687 165 8.2 118 5.2 < .001 .942
    Psychiatric 361 7.8 417 5.0 < .001 .939 742 8.5 288 5.1 < .001 .763 183 9.1 122 5.4 < .001 .982
    Electrolyte abnormality 403 8.7 516 6.2 < .001 .980 809 9.3 405 7.2 < .001 .924 201 10.0 166 7.3 .0027 .946
    Arrhythmia 882 19.0 1619 19.5 .463 .978 2,460 28.3 1,425 25.2 < .001 .887 559 27.7 511 22.6 < .001 .974
    Coronary artery disease 559 12.0 993 12.0 .952 .933 1,142 13.1 702 12.4 .230 .979 267 13.2 266 11.8 .160 .975
    Hypertension 2,907 62.6 5,302 64.0 .119 .849 5,828 67.0 3,787 67.1 .975 .937 1,420 70.4 1,564 69.2 .413 .896
    COPD 1,155 24.9 1,793 21.6 < .001 .959 2,185 25.1 1,201 21.3 < .001 .873 521 25.8 474 21.0 < .001 .977
    Liver 239 5.1 328 4.0 .002 .968 327 3.8 239 4.2 .169 .964 84 4.2 107 4.7 .408 .926
    Renal 272 5.9 355 4.3 < .001 .994 639 7.3 266 4.7 < .001 .866 172 8.5 138 6.1 .003 .950
    Diabetes 1,209 26.0 2,037 24.6 .072 .960 2,033 23.4 1,314 23.3 .894 .946 548 27.2 644 28.5 .352 .993
    Bleeding disorder 161 3.5 291 3.5 .933 .908 377 4.3 246 4.4 .986 .959 111 5.5 108 4.8 .315 .956
    Weight loss 114 2.5 117 1.4 < .001 .987 276 3.2 123 2.2 < .001 .942 89 4.4 55 2.4 < .001 .931
    Anemia 893 19.2 1,283 15.5 < .001 .931 1,858 21.4 1,102 19.5 .008 .956 468 23.2 470 20.8 .063 .896
Size of urban area .011 .890 < .001 .829 .001 .992
    ≥ 1 million 2,512 54.1 4,259 51.4 4,496 51.7 3,140 55.6 1,114 55.2 1,316 58.2
    250,000 to 1 million 832 17.9 1,604 19.4 1,689 19.4 1,096 19.4 352 17.5 434 19.2
    < 250,000 1,298 28.0 2,419 29.2 2,509 28.9 1,410 25.0 551 27.3 510 22.6
Census tract median income, $ < .001 .940 < .001 .823 < .001 .924
    0 to 25,000 752 16.2 956 11.5 1,159 13.3 445 7.9 289 14.3 195 8.6
    25,000 to 40,000 1,645 35.4 2,634 31.8 2,958 34.0 1,728 30.6 635 31.5 591 26.2
    40,000 to 60,000 1,371 29.5 2,733 33.0 2,788 32.1 1,891 33.5 634 31.4 708 31.3
    ≥ 60,000 815 17.6 1,821 22.0 1,679 19.3 1,480 26.2 445 22.1 727 32.2
    Unknown 59 1.3 138 1.7 110 1.3 102 1.8 14 0.7 39 1.7

NOTE. Year, SEER registry, and urologist practice years were balanced within propensity score quintiles but are not shown for presentation purposes.

Abbreviations: ADT, androgen-deprivation therapy; COPD, chronic obstructive pulmonary disease; RCT, randomized clinical trial; RT, radiotherapy; SD, standard deviation.